Procurement Summary
Country: USA
Summary: Dow Melanoma Research Program Survivorship Research Award
Deadline: 14 Oct 2026
Posting Date: 22 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141809731
Document Ref. No.: HT942526MRPSRA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
73110000 - Research services
73210000 - Research consultancy services
33652000 - Antineoplastic and immunomodulating agents
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Fiscal Year 2026 (Fy26) Melanoma Research Program (Mrp) Survivorship Research Award Addresses The Relatively New And Underfunded Area Of Melanoma-Specific Survivorship By Supporting A Broad Range Of Innovative And Impactful Research That Has The Intended Outcome Of Improving The Health And Well-Being Of Melanoma Survivors, Their Families And/Or Their Care Partners In The Near Term. Proposed Studies Focusing Exclusively On Animal Models Or Considering Survival Only Without Consideration Of Quality Of Life, Overall Health And/Or Function Are Not Responsive To This Funding Opportunity.... Distinctive Features: ·
Posted Date: 2026-05-21 00:00:00
Funding instrument type: Grant
Documents
Tender Notice